Companies
Companies
Abzena taps into ProteoNic’s viral vector tech
🔍 Abzena has partnered with ProteoNic to use its viral vector technology in the development of biotechnology products. 🧬 This technology is used to deliver genetic material into cells, making it an important tool in gene therapy and biopharmaceutical manufacturing. 💉 The partnership will allow Abzena to enhance its capabilities in viral vector manufacturing and offer a more efficient and streamlined process for its clients. 🚀 This collaboration highlights the growing importance of viral vector technology in the biotech industry.
Gene therapy firm Locanabio to close by end of 2023
⚠️ Gene therapy firm Locanabio will close by the end of 2023. 🧬🔬 It is unclear why the company is shutting down. 💔🏭 The closure will likely have an impact on the development of gene therapies. 🌍👥 Locanabio was focused on creating therapies for neurodegenerative diseases. 🧠💊
Moderna sets sights on 2025 for return to growth after COVID slump
📰 Moderna, a biotechnology company, plans to return to growth by 2025 after the COVID-19 pandemic setback. 🏭 The company expects that its mRNA platform will continue to be important in the development of new medicines. 💊 Moderna aims to expand its portfolio beyond COVID-19 vaccines and focus on other therapeutic areas. 🤝 Partnerships and collaborations with other companies will be crucial for Moderna's future growth. 💰 The company also plans to invest in manufacturing and infrastructure to support its growth strategy.
BioCina partners with GPN Vaccines against Streptococcus pneumoniae
📢 BioCina has partnered with GPN Vaccines to develop a vaccine against Streptococcus pneumoniae. 🔬💉 This partnership will leverage the expertise of both companies to accelerate the development of the vaccine. 🚀 Streptococcus pneumoniae is a common cause of pneumonia, meningitis, and other infections worldwide. 💊🌍 The vaccine will aim to prevent these infections and reduce the burden on healthcare systems. 💪🏥 By combining their resources, BioCina and GPN Vaccines hope to make a significant impact in the fight against Streptococcus pneumoniae. 🤝✨
With reworked gov grant, it’s back to business for Valneva Scotland plant
📰 The Valneva Scotland plant is back in business after receiving a reworked government grant. 💰 🏭 The plant, which specializes in biotechnology, had faced uncertainty after the European Commission terminated its COVID-19 vaccine contract. ❌ 🌱 However, the Scottish government has now amended its grant to support the plant's reopening. 💪 👥 This is good news for the local economy and the biotechnology industry. 🌍
